Loading company…
Saide Dikang develops medical restorative materials and wound repair products.
Saide Dikang develops materials and products for acute and chronic wound care. Its PermeaDerm biosynthetic membrane is based on the company’s proprietary technology platform and is used in wound repair, surgery, orthopedics, neurology and cardiovascular care. Founded in 2019, it is based in Hangzhou, China, with research and production sites in China and the United States. In February 2025, it raised Series B funding from Lapam Capital and Samuel Guo.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in